Avita Medical | 1811094D - 资产

股票价格
1.25
每天变化
-0.02 -1.57%
每月一次
3.31%
每年
-56.90%
Q1 预测
1.23


金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 164.6M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


资产 更改 日
Accuray USD 456.82M 13.42M 2025-09
Celltrion KRW 21.08T 530.63B 2025-09
Clinuvel Pharmaceuticals AUD 231.12M 19.44M 2024-06
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Cspc Pharmaceutical CNY 46B 1.61B 2025-06
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 1.05B 10.63M 2025-09
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Mayne Pharma AUD 1.14B 9.47M 2024-06
Medical Developments International AUD 63.57M 2.83M 2025-12
Nanosonics AUD 279.25M 6.77M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 562.21M 2.4M 2025-09
Ovoca Bio EUR 11.41M 3.36M 2022-06
Pacific Edge NZD 34.66M 2.37M 2025-12
Paradigm Biopharmaceuticals AUD 24.57M 10.79M 2025-06
Pharma Mar EUR 395.08M 53.42M 2025-12
Polynovo AUD 108.72M 11.51M 2024-06
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Qiagen NV USD 6.3B 257.54M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Sartorius EUR 9.61B 413.4M 2025-09
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Telix Pharmaceuticals AUD 1.16B 25.97M 2025-12
Tilray USD 2.07B 1.33B 2025-03
Zz Pientze Pharmaceu CNY 17.48B 1.23B 2025-09